Susquehanna Portfolio Strategies, LLC Relay Therapeutics, Inc. Transaction History
Susquehanna Portfolio Strategies, LLC
- $4.3 Trillion
- Q1 2024
A detailed history of Susquehanna Portfolio Strategies, LLC transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Susquehanna Portfolio Strategies, LLC holds 208,356 shares of RLAY stock, worth $1.86 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
208,356
Previous 210,003
0.78%
Holding current value
$1.86 Million
Previous $2.31 Billion
25.21%
% of portfolio
0.04%
Previous 0.04%
Shares
2 transactions
Others Institutions Holding RLAY
# of Institutions
190Shares Held
127MCall Options Held
4.2KPut Options Held
1.7K-
Sb Investment Advisers (Uk) LTD London, X027.9MShares$249 Million2.29% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$106 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.8MShares$87.5 Million0.0% of portfolio
-
Casdin Capital, LLC New York, NY7.42MShares$66.3 Million4.98% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.88MShares$61.4 Million0.01% of portfolio
About Relay Therapeutics, Inc.
- Ticker RLAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 120,219,000
- Market Cap $1.07B
- Description
- Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...